dimethyl sulfone has been researched along with Metabolic Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, M; Gaspar, JM; Jung, HJ; Kang, MC; Kim, YB; Lee, SH; Macedo, MP; Mantzoros, C; Park, KS; Park, SY; Seo, JA; Sousa-Lima, I | 1 |
Engelke, UF; Loss, S; Moskau, D; Mudd, SH; Tangerman, A; Wevers, RA; Willemsen, MA | 1 |
1 trial(s) available for dimethyl sulfone and Metabolic Diseases
Article | Year |
---|---|
Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional (1)H and two-dimensional (1)H-(13)C NMR.
Topics: Adolescent; Adult; Aged; Biomarkers; Carbon Isotopes; Child; Child, Preschool; Dimethyl Sulfoxide; Female; Humans; Infant; Infant, Newborn; Magnetic Resonance Spectroscopy; Male; Metabolic Diseases; Middle Aged; Nervous System Diseases; Protons; Sulfones | 2005 |
1 other study(ies) available for dimethyl sulfone and Metabolic Diseases
Article | Year |
---|---|
Methylsulfonylmethane (MSM), an organosulfur compound, is effective against obesity-induced metabolic disorders in mice.
Topics: 3T3-L1 Cells; Animals; Anti-Obesity Agents; B-Lymphocytes; Blood Glucose; Cholesterol; Diet, High-Fat; Dimethyl Sulfoxide; Femur; Gene Expression; Insulin Resistance; Lipid Metabolism; Liver; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Obese; Myeloid Cells; Obesity; Sulfones; Triglycerides | 2016 |